|
| 36209944 | Association between self-reported masking behavior and SARS-CoV-2 infection wanes from Pre-Delta to Omicron-predominant periods - North Carolina COVID-19 Community Research Partnership (NC-CCRP). | Am J Infect Control | 2023 |
| 37632364 | High costs of cardiovascular disease in the European Union. | Eur Heart J | 2023 |
| 37738645 | Can we measurably improve the prediction of recurrent coronary artery disease events? | Eur Heart J | 2023 |
| 37609913 | Reduced heart failure-related healthcare costs with Furoscix versus in-hospital intravenous diuresis in heart failure patients: the FREEDOM-HF study. | Future Cardiol | 2023 |
| 37544553 | Determinants of Health and Outcomes in Medicare Recipients With Heart Disease: A Population Study. | J Pain Symptom Manage | 2023 |
| 37459570 | Thrombotic risk in patients with acute coronary syndromes discharged on prasugrel or clopidogrel: results from the PROMETHEUS study. | Eur Heart J Acute Cardiovasc Care | 2023 |
| 37380505 | Editorial: Incidence, disparities and outcome of acute coronary syndromes: Implications for health care systems. | Cardiovasc Revasc Med | 2023 |
| 37378472 | Estimated Population Health Benefits of Intensive Systolic Blood Pressure Treatment Among SPRINT-Eligible US Adults. | Am J Hypertens | 2023 |
| 37009915 | Characterisation of infection-induced SARS-CoV-2 seroprevalence amongst children and adolescents in North Carolina. | Epidemiol Infect | 2023 |
| 37204788 | Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical Trial. | JAMA Netw Open | 2023 |
| 37069033 | Factors associated with COVID-19 vaccination during June-October 2021: A multi-site prospective study. | Vaccine | 2023 |
| 36725179 | Evolving Management Paradigm for Stable Ischemic Heart Disease Patients: JACC Review Topic of the Week. | J Am Coll Cardiol | 2023 |
| 36725175 | Improving the Quality of Life for Patients With Heart Failure and Preserved Ejection Fraction. | J Am Coll Cardiol | 2023 |
| 36519451 | Antihypertensive Medication Regimens Used in the Systolic Blood Pressure Intervention Trial. | Hypertension | 2023 |
| 36441173 | Left ventricular anatomy in obstructive hypertrophic cardiomyopathy: beyond basal septal hypertrophy. | Eur Heart J Cardiovasc Imaging | 2023 |
| 36648040 | 3-Dimensional Strain Analysis of Hypertrophic Cardiomyopathy: Insights From the NHLBI International HCM Registry. | JACC Cardiovasc Imaging | 2023 |
| 36912842 | The Economic Burden of Illness. | JAMA Netw Open | 2023 |
| 36427605 | Percutaneous coronary intervention from COURAGE to ISCHEMIA and beyond. | Int J Cardiol | 2023 |
| 36604293 | Diagnosing coronary artery disease and cost of care. | J Cardiovasc Comput Tomogr | 2023 |
| 36573634 | COVID-19 Symptoms by Variant Period in the North Carolina COVID-19 Community Research Partnership, North Carolina, USA. | Emerg Infect Dis | 2023 |
| 36932031 | Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March-October, 2021. | Vaccine | 2023 |
| 36598836 | Genome-Wide Analysis of Left Ventricular Maximum Wall Thickness in the UK Biobank Cohort Reveals a Shared Genetic Background With Hypertrophic Cardiomyopathy. | Circ Genom Precis Med | 2023 |
| 33215693 | Estimating the optimal individualized treatment rule from a cost-effectiveness perspective. | Biometrics | 2022 |
| 35706687 | Self-reported mask use among persons with or without SARS CoV-2 vaccination -United States, December 2020-August 2021. | Prev Med Rep | 2022 |
| 35834254 | Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT). | JAMA Netw Open | 2022 |
| 35574517 | The potential population health impact of treating REDUCE-IT eligible US adults with Icosapent Ethyl. | Am J Prev Cardiol | 2022 |
| 35597719 | Revascularization for Stable Ischemic Heart Disease: The Beat Goes On. | Cardiovasc Revasc Med | 2022 |
| 35419927 | Safety gaps in medical team communication: Closing the loop on quality improvement efforts in the cardiac catheterization lab. | Catheter Cardiovasc Interv | 2022 |
| 35447337 | Beta-blockers and Ambulatory Inotropic Therapy. | J Card Fail | 2022 |
| 35446945 | Frailty and COVID-19 mRNA Vaccine Antibody Response in the COVID-19 Community Research Partnership. | J Gerontol A Biol Sci Med Sci | 2022 |
| 36462514 | The burden of cardiovascular disease attributable to high systolic blood pressure across China, 2005-18: a population-based study. | Lancet Public Health | 2022 |
| 36423018 | Breakthrough SARS-CoV-2 Infections after Vaccination in North Carolina. | Vaccines (Basel) | 2022 |
| 36482096 | Association of Obesity and Diabetes with SARS-Cov-2 Infection and Symptoms in the COVID-19 Community Research Partnership. | J Clin Endocrinol Metab | 2022 |
| 36449517 | Health, social, and economic characteristics of patients enrolled in a COVID-19 recovery program. | PLoS One | 2022 |
| 35912490 | An efficient approach for optimizing the cost-effective individualized treatment rule using conditional random forest. | Stat Methods Med Res | 2022 |
| 36201099 | Machine learning evaluation of LV outflow obstruction in hypertrophic cardiomyopathy using three-chamber cardiovascular magnetic resonance. | Int J Cardiovasc Imaging | 2022 |
| 35891180 | Self-Reported SARS-CoV-2 Vaccination Is Consistent with Electronic Health Record Data among the COVID-19 Community Research Partnership. | Vaccines (Basel) | 2022 |
| 36257844 | Comparison of Outcomes of Invasive or Conservative Management of Chronic Coronary Disease in Four Randomized Controlled Trials. | Am J Cardiol | 2022 |
| 35918234 | Comparison of Characteristics and Outcomes of Veterans With Stable Ischemic Heart Disease Enrolled in the COURAGE Trial Versus the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. | Am J Cardiol | 2022 |
| 33878073 | A meta-analysis of optimal medical therapy with or without percutaneous coronary intervention in patients with stable coronary artery disease. | Coron Artery Dis | 2022 |
| 35157055 | Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment. | JAMA Netw Open | 2022 |
| 35089354 | Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment. | JAMA Netw Open | 2022 |
| 35033221 | What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation? | Lancet | 2022 |
| 35339451 | Preexisting frailty and outcomes in older patients with acute myocardial infarction. | Am Heart J | 2022 |
| 34922841 | Reducing Racial/Ethnic Disparities in Palliative Care for Stroke Patients. | Cardiovasc Revasc Med | 2022 |
| 34474157 | Characteristics and Outcomes of Patients with Inflammatory Cardiomyopathies Receiving Mechanical Circulatory Support: An STS-INTERMACS Registry Analysis. | J Card Fail | 2022 |
| 34610297 | The Rising Urgency to Pivot Back Toward Hippocratic Medicine. | Am J Med | 2022 |
| 33091365 | National trends and 30-day readmission rates for next-day-discharge transcatheter aortic valve replacement: An analysis from the Nationwide Readmissions Database, 2012-2016. | Am Heart J | 2021 |
| 33563623 | Cost-effectiveness analysis of percutaneous coronary intervention for single-vessel coronary artery disease: an economic evaluation of the ORBITA trial. | BMJ Open | 2021 |
| 33755495 | 2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure). | Circ Cardiovasc Qual Outcomes | 2021 |